These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 6295007)

  • 1. Immortalization of human lymphocytes by Epstein-Barr virus.
    Miller G
    Yale J Biol Med; 1982; 55(3-4):305-10. PubMed ID: 6295007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regions of the EBV genome involved in latency and lymphocyte immortalization.
    Miller G
    Prog Med Virol; 1984; 30():107-28. PubMed ID: 6087408
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
    Hammerschmidt W; Sugden B
    Nature; 1989 Aug; 340(6232):393-7. PubMed ID: 2547164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing faces of EBV research.
    Klein G; Klein E
    Prog Med Virol; 1984; 30():87-106. PubMed ID: 6087416
    [No Abstract]   [Full Text] [Related]  

  • 5. Process of immortalization by Epstein-Barr virus and oncogenic conversion of the immortalized cells.
    Nonoyama M; Tanaka A; Ozaki H
    AIDS Res; 1986 Dec; 2 Suppl 1():S103-8. PubMed ID: 2881553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV expression in human non-lymphoid hematopoietic cell lines.
    Rocchi G; Ragona G; Revoltella RP
    Prog Med Virol; 1984; 30():129-38. PubMed ID: 6087409
    [No Abstract]   [Full Text] [Related]  

  • 7. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T; Sjöblom A; Masucci MG; Rymo L
    Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides.
    Meerbach A; Friedrichs C; Thust R; Wutzler P
    Arch Virol; 2004 Jun; 149(6):1083-94. PubMed ID: 15168196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of EBV transforming genes by recombinant EBV technology.
    Izumi KM
    Semin Cancer Biol; 2001 Dec; 11(6):407-14. PubMed ID: 11669602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R
    Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of human B-lymphocyte replication. II. Transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B-cell growth.
    Gordon J; Walker L; Guy G; Brown G; Rowe M; Rickinson A
    Immunology; 1986 Aug; 58(4):591-5. PubMed ID: 2426189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
    Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
    J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immortalization of Epstein-Barr virus-negative human B lymphocytes with minimal chromosomal instability.
    Yamashita Y; Tsurumi T; Mori N; Kiyono T
    Pathol Int; 2006 Nov; 56(11):659-67. PubMed ID: 17040288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular mechanisms of establishment and disruption of Epstein-Barr virus latency].
    Takada K
    Tanpakushitsu Kakusan Koso; 1989 Jun; 34(7):823-34. PubMed ID: 2552500
    [No Abstract]   [Full Text] [Related]  

  • 15. Epstein-Barr virus infection of rat lymphocytes expressing human CD21 results in restricted latent viral gene expression and not in immunoblastic transformation.
    Yang L; Ikeda H; Lai Y; Yoshiki T; Takada K
    J Med Virol; 2003 May; 70(1):126-30. PubMed ID: 12629653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Epstein-Barr virus genome and phenotypic expression during lytic cycle.
    Pearson GR
    AIDS Res; 1986 Dec; 2 Suppl 1():S49-56. PubMed ID: 3030347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the association of the Epstein-Barr virus genome and human chromosomes.
    Glaser R; Nonoyama M; Hampar B; Croce CM
    J Cell Physiol; 1978 Sep; 96(3):319-25. PubMed ID: 209053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient foreign gene expression in Epstein-Barr virus-transformed human B-cells.
    Curiel TJ; Cook DR; Bogedain C; Jilg W; Harrison GS; Cotten M; Curiel DT; Wagner E
    Virology; 1994 Feb; 198(2):577-85. PubMed ID: 8291240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation.
    Yajima M; Kanda T; Takada K
    J Virol; 2005 Apr; 79(7):4298-307. PubMed ID: 15767430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.